EUROFINS SCIENTIFIC : Eurofins scientists deliver key contributions to Allergen threshold Discussion and ELISA Validation
31 March 2010
The introduction of maximum thresholds and action levels for food allergens has been intensely debated across countries that have allergen labelling regulations in place. The intention is that these thresholds will help industry to protect their customers and regulators to enforce legislation. Eurofins Scientists have authored and co-authored two publications in the reputable, peer-reviewed Journal of AOAC International, pointing the way forward.
The paper by Dr. Carmen Diaz-Amigo and Dr. Bert Popping discusses the introduction of thresholds or action levels for allergen labelling and it clearly shows the benefits and limits of existing and emerging testing methodologies. Furthermore, the authors suggest how industry, despite some methodological uncertainties, can make meaningful risk-management decisions based on analytical results and how regulators can approach the formulation of wording within legislation regarding action levels, taking method variability into account.
The second publication (Abbott et al.) on validation guidelines for food allergen ELISA assays is a milestone in harmonizing the way validation is conducted. It summarizes the outcome of intensive work by experts worldwide over the last three years. The guidance provided in the document will lead to more robust, reliable and cohesive analytical results, allowing industry to integrate analytical testing as a valid tool into the allergen control risk-management decision processes. It will also enable food agencies to enforce existing legislation better. This publication is co-authored by Dr. Bert Popping as well as other experts from Health Canada, the European Commission, the Australian National Measurements Institute, Nestlé Nutrition, FARRP and ICC.
Eurofins therefore is not only directly helping its clients in their analyses and interpretation of results, but it also actively engages with industry and legislators to help drive forward the development of appropriate technical innovation and modern risk evaluation tools for the ultimate benefit of the consumer. This is a consequence of the scientific expertise and experience to be found within the Group and the recognition of this status by participation on panels like the AOAC. By contributing towards the cutting edge of development and information at the international level, Eurofins is a market-leader in translating this expertise into the highest-quality results for its client.
These publications, as well as an introductory article written by Dr. Bert Popping (Eurofins) and Dr. Michael Abbott (Health Canada) will appear in a special allergen section of the current issue of Journal of AOAC International (VOL. 93, NO. 2, 2010). The announcement can be found on the AOAC website:
For further information please contact:
Dr. Bert Popping
Phone: +49 40 492 94 600
Phone: +32 2 766 1620
Notes for the editor:
Eurofins - a global leader in bio-analysis
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors.
With 8,000 staff in more than 150 laboratories across 30 countries, Eurofins offers a portfolio of over 40,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to providing its customers with high quality services, accurate results in time and, if requested, expert advice by its highly qualified staff.
The Eurofins Group is the world leader in food testing and one of the global market leaders in pharmaceuticals and environmental testing. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910 251) Stock Exchanges (Reuters EUFI.PA, Bloomberg ERF FP).
AOAC INTERNATIONAL is a global scientific association dedicated to the development and validation of analytical methods, the improvement of quality assurance procedures in laboratories and the professional development of analytical scientists around the world.
AOAC INTERNATIONAL members include leading decision-makers from government, academia, and industry working in the areas of foods and beverages, feeds, fertilizers, soil and water, pharmaceuticals, and cosmetics.
AOAC INTERNATIONAL is growing rapidly with unprecedented increases in membership, readership, and meeting attendance. All exhibit spaces for the 2009 AOAC Annual Meeting were sold out well in advance of the exposition, and membership and subscriptions to AOAC publications continue to grow rapidly.
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.Information non réglementée
Communiqué intégral et original au format PDF :
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free